Metabolic Disorders

Clinicians should discuss alternative weight-loss medications and strategies with patients.

Higher doses anti-tumor necrosis factor-α (anti-TNF-α) therapy may be neceessary for obese patients with ulcerative colitis (UC), according to the findings of a recently published meta-analysis.

Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.